Sang-gon Park
Gwangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Antibody-Mediated Therapy in Gastric Cancer: Past, Present, and Future.
Journal: Current issues in molecular biology
Published: November 18, 2025
Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19).
Journal: Cancer research and treatment
Published: November 18, 2025
POM121 Drives Gastric Cancer Progression via the mTOR/p70S6K Signaling Axis.
Journal: Anticancer research
Published: November 05, 2025
Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway.
Journal: Anticancer research
Published: October 31, 2025
NPM1 Drives ERK1/2-dependent Tumor Progression in Lung Cancer.
Journal: Cancer genomics & proteomics
Published: October 31, 2025
SLX1 Inhibition Enhances Olaparib Sensitivity by Impairing Homologous Recombination Repair in Breast Cancer.
Journal: International journal of molecular sciences
Published: October 15, 2025
Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer via PI3K/AKT/mTOR Signaling.
Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer via PI3K/AKT/mTOR Signaling.
Journal: Anticancer research
Published: October 14, 2025
Capillary Hemangioma of the Breast Parenchyma Mimicking New Primary Cancer or Metastasis During Ramucirumab Therapy for Advanced Gastric Cancer.
Journal: In vivo (Athens, Greece)
Published: September 12, 2025
Down-regulation of ACSM3 Promotes Tumorigenesis in Breast Cancer.
Journal: Anticancer research
Published: September 05, 2025
Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4/6 Pathway.
Journal: Head & neck
Published: July 24, 2025
GNAO1: A Novel Tumor Suppressor Gene in Colorectal Cancer Pathogenesis.
Journal: Anticancer research
Published: October 25, 2024
Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy.
Journal: Cancer research and treatment
Published: August 28, 2024
Last Updated: 09/26/2026